Garrett Park, MD, United States of America

Curtis C Harris

USPTO Granted Patents = 58 


 

Average Co-Inventor Count = 2.8

ph-index = 12

Forward Citations = 342(Granted Patents)


Inventors with similar research interests:


Location History:

  • Garrett Park, MD (US) (2003 - 2018)
  • Bethesda, MD (US) (1981 - 2023)

Company Filing History:


Years Active: 1981-2023

Loading Chart...
Loading Chart...
Loading Chart...
58 patents (USPTO):

Title: **Curtis C. Harris: A Trailblazer in Cancer Diagnosis and Prognosis Innovations**

Introduction

Curtis C. Harris is a prominent inventor based in Garrett Park, MD, recognized for his impactful contributions in the field of cancer research. With a remarkable portfolio of 58 patents, Harris has been pivotal in developing innovative methods for diagnosing and prognosing cancer, driving advancements that could change patient outcomes significantly.

Latest Patents

Harris's latest patents focus on a groundbreaking method for the diagnosis and prognosis of cancer. This invention provides methods and materials for diagnosing cancer in individuals using tissue, blood, or urine samples. The innovative approach involves determining the levels of key metabolites, including creatine riboside, metabolite 561+, cortisol sulfate, and N-acetylneuraminic acid. Furthermore, the patent also encompasses kits designed for detecting cancer and assisting in prognostic assessments for cancer patients, showing immense potential for clinical application.

Career Highlights

Throughout his career, Curtis C. Harris has held key roles in esteemed organizations. Notably, he contributed significantly while working with the Ohio State University Research Foundation and the United States Department of Health and Human Services. His dedication to advancing cancer research has led to numerous developments that have positioned him as a leader in the field.

Collaborations

Collaboration has been a vital aspect of Harris's work. He has had the opportunity to work alongside esteemed colleagues, including Carlo M. Croce and Makoto Nagashima. These partnerships have fostered the collective goal of advancing research and therapies that can enhance patient care in oncology.

Conclusion

Curtis C. Harris's innovative spirit and commitment to cancer research are reflected in his extensive patent portfolio and collaborative efforts. With ongoing advancements in cancer diagnosis and prognosis, Harris continues to make significant contributions that hold promise for the future of medicine. His work exemplifies the vital role inventors play in transforming healthcare and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…